経口タンパク質・ペプチド市場 薬剤タイプ(リナクロチド、プレカナチド、カルシトニン、インスリン、オクトレオチド)、用途(胃・消化器疾患、骨疾患、糖尿病、ホルモン疾患)、地域別 2025-2033

経口タンパク質・ペプチド市場 薬剤タイプ(リナクロチド、プレカナチド、カルシトニン、インスリン、オクトレオチド)、用途(胃・消化器疾患、骨疾患、糖尿病、ホルモン疾患)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A25498

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Oral Proteins and Peptides Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Type
    6.1    Linaclotide
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Plecanatide
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Calcitonin
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Insulin
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Octreotide
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Application
    7.1    Gastric and Digestive Disorders
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Bone Diseases
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Diabetes
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Hormonal Disorders
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   Drivers, Restraints, and Opportunities
    9.1    Overview
    9.2    Drivers
    9.3    Restraints
    9.4    Opportunities
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Amryt Pharma Plc 
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
        13.3.2    AstraZeneca PLC
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Biocon Limited
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Novo Nordisk A/S
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Oramed Ltd
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Proxima Concepts Limited
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2024
Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2024
Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2024
Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2024
Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
Table 6: Global: Oral Proteins and Peptides Market: Key Players​

経口タンパク質・ペプチド市場 薬剤タイプ(リナクロチド、プレカナチド、カルシトニン、インスリン、オクトレオチド)、用途(胃・消化器疾患、骨疾患、糖尿病、ホルモン疾患)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials